Contineum Therapeutics, Inc. (CTNM)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
7. 08
-0.82
-10.3797%
$
503.37M Market Cap
- P/E Ratio
- Div Yield
1.11M Volume
- Eps
$ 7.9
Previous Close 
Want to track CTNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Contineum Therapeutics, Inc. (CTNM) Statistics
Valuation metrics
Market Cap 503.37M
Enterprise value 495.23M
Trailing P/E (ttm) -7.73
Forward P/E -
PEG ratio -0.32
Price/Sales (ttm) -
Price/Book (mrq) 2.09
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.5
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.09M
Average volume (90 days) 833.13K
Price summary
52-Week low 6.95
52-Week high 17.79
Beta -
50-Day moving average 13.63
200-Day moving average 13.49
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.23%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 37.17%
Book value per share (mrq) 6.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
